Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Int. braz. j. urol ; 42(2): 373-382, Mar.-Apr. 2016. tab, graf
Article in English | LILACS | ID: lil-782845

ABSTRACT

ABSTRACT Objective: To establish the detrusor overactivity (DO) model induced by visceral hypersensitivity (VH) and investigate the relationship between mast cell (MC) infiltration and DO. Materials and Methods: Sixty rats are divided into 4 groups randomly: Group 1:Baseline group; Group 2: DO group; Group 3: CON group; Group 4: VH group. The colorectal distension (CRD) and abdominal withdral reflex (AWR) scores are performed to evaluate VH. The cystometric investigation and histological test of MC infiltration are assessed. Results: The threshold pressure of CRD in the VH group is significantly lower than that in the CON group (P<0.001). At the distension pressure ≥20 mmHg, the AWR scores of the VH group are significantly higher than those of the CON group (10 mmHg: P=0.33; 20 mmHg: P=0.028; 40 mmHg: P<0.001; 60 mmHg: P<0.001; 80 mmHg: P<0.001). DO model is successfully established in the VH group (DO rate=100%). Compared with the CON group, the numbers of MC infiltration are significantly increased in the VH group, including submucosa of bladder (P<0.001), mucosa lamina propria/mesentery of small intestine (P<0.001), and mucosa lamina propria/mesentery of large intestine (P<0.001). Furthermore, more MC activation as well as degranulation are observed in the VH group. Conclusions: It is indicated that DO model can be established in the VH rats. The MC infiltration may play an important role in DO induced by VH, and may be helpful to understand the mechanisms of DO in VH patients.


Subject(s)
Animals , Female , Viscera/physiopathology , Disease Models, Animal , Urinary Bladder, Overactive/etiology , Urinary Bladder, Overactive/physiopathology , Hypersensitivity/complications , Hypersensitivity/physiopathology , Mast Cells/pathology , Pressure , Urodynamics , Viscera/pathology , Random Allocation , Reproducibility of Results , Rats, Wistar , Irritable Bowel Syndrome/complications , Irritable Bowel Syndrome/physiopathology , Irritable Bowel Syndrome/pathology , Urinary Bladder, Overactive/pathology , Visceral Pain/complications , Visceral Pain/physiopathology , Visceral Pain/pathology , Hypersensitivity/pathology , Intestines/physiopathology , Intestines/pathology
2.
Int. braz. j. urol ; 41(6): 1141-1147, Nov.-Dec. 2015. tab, graf
Article in English | LILACS | ID: lil-769751

ABSTRACT

Objectives: To evaluate the expression of sphingosine kinase 1 (SPK1) in the bladder wall in patients with neurogenic lower urinary tract dysfunction and its association with clinical, urodynamic and pathological features. Materials and Methods: The expression of SPK1 was studied in bladder wall specimens obtained from cystectomy using immunohistochemistry in ten patients with spinal cord injury (n=8) or multiple sclerosis (n=2) with urodynamically proven neuropathic bladder dysfunction, and in controls (n=5). Inflammation and fibrosis were analysed with histological criteria and SPK1 expression was determined by individual immunohistochemical staining. Results: Significant increased SPK1 urothelial immunoreactivity was shown in patients compared to control group (p=0.03). By contrast, SPK1 immunoreactivity in patients was significantly decreased in the sub-urothelium, muscles and nerves, p=0.02; 0.01 and 0.003, respectively. Patients with neurogenic detrusor overactivity (NDO) had higher SPK1 urothelium expression than those without any DO (p=0.04). Conclusions: SPK1 is expressed in the human bladder wall, specifically the urothelium, in bladder specimens from patients with NDO. The role of SPK1 in the pathophysiology of NDO needs further elucidation.


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Phosphotransferases (Alcohol Group Acceptor)/analysis , Spinal Cord Injuries/complications , Urinary Bladder, Overactive/enzymology , Biopsy , Fibrosis , Immunohistochemistry , Multiple Sclerosis/complications , Phosphotransferases (Alcohol Group Acceptor)/metabolism , Urodynamics , Urinary Bladder, Overactive/etiology , Urinary Bladder, Overactive/pathology , Urinary Bladder/pathology , Urothelium/pathology
SELECTION OF CITATIONS
SEARCH DETAIL